Background/Aims: Retinol-binding protein 4 (RBP4) has been shown to be associated with insulin resistance and fatty acid metabolism. We hypothesize that RBP4 might play a role in fetal growth and that cord serum RBP4 may act as a marker of fetal growth, independent of fetal insulin levels. Methods: Twenty-one women having fetuses in the top quartile (>75th percentile) of birth weights for gestational age were enrolled into the trial, along with 21 women having fetuses in the bottom quartile (<25th percentile) of birth weights for gestational age. Serum RBP4 and insulin levels were analyzed. Results: Cord serum RBP4 and insulin concentrations were significantly higher in the top quartile group (14.3 ± 3.7 ng/ml, 3.8 ± 5.2 µIU/ml) than in the bottom quartile group (11.3 ± 2.6 ng/ml, 0.9 ± 1.4 µIU/ml; p = 0.004, p = 0.017). Cord serum RBP4 and insulin as well as gestational age (r = 0.744, r2 = 0.553, p < 0.001) were significantly correlated with fetal birth weights. Conclusion: Cord serum RBP4 concentrations were higher in subjects with top quartile fetuses than in those with bottom quartile fetuses. Cord serum RBP4 concentrations were significantly correlated with fetal birth weight. These findings may indicate that cord serum RBP4 plays a regulatory role in fetal growth.

Keywords:
Retinol-binding protein 4, Fetal growth, Cord serum
1.
Quadro L, Hamberger L, Colantuoni V, Gottesman ME, Blaner WS: Understanding the physiological role of retinol-binding protein in vitamin A metabolism using transgenic and knockout mouse models. Mol Aspects Med 2003;24:421–430.
2.
Noy N: Retinoid-binding proteins: mediators of retinoid action. Biochem J 2000;348:481–495.
3.
Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB: Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356–362.
4.
Muoio DM, Newgard CB: Metabolism: A is for adipokine. Nature 2005;436:337–338.
5.
McGarry JD: Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002;51:7–18.
6.
Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB: Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552–2563.
7.
Chan TF, Chen HS, Chen YC, Lee CH, Chou FH, Chen IJ, Chen SY, Jong SB, Tsai EM: Increased serum retinol-binding protein 4 concentrations in women with gestational diabetes mellitus. Reprod Sci 2007;14:169–174.
8.
Langer O: Fetal macrosomia: etiologic factors. Clin Obstet Gynecol 2000;43:283–297.
9.
Sermer M, Naylor CD, Gare DJ, Kenshole AB, Ritchie JW, Farine D, Cohen HR, McArthur K, Holzapfel S, Biringer A, et al: Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995;173:146–156.
10.
Di Cianni G, Miccoli R, Volpe L, Lencioni C, Ghio A, Giovannitti MG, Cuccuru I, Pellegrini G, Chatzianagnostou K, Boldrini A, Del Prato S: Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med 2005;22:21–25.
11.
Kitajima M, Oka S, Yasuhi I, Fukuda M, Rii Y, Ishimaru T: Maternal serum triglyceride at 24–32 weeks’ gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol 2001;97:776–780.
12.
Nolan CJ, Riley SF, Sheedy MT, Walstab JE, Beischer NA: Maternal serum triglyceride, glucose tolerance, and neonatal birth weight ratio in pregnancy. Diabetes Care 1995;18:1550–1556.
13.
Lee DC, Lee JW, Im JA: Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism 2007;56:327–331.
14.
Erikstrup C, Mortensen OH, Pedersen BK: Retinol-binding protein 4 and insulin resistance. N Engl J Med 2006;355:1393–1394; author reply 1394–1395.
15.
Qi Q, Yu Z, Ye X, Zhao F, Huang P, Hu FB, Franco OH, Wang J, Li H, Liu Y, Lin X: Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 2007;92:4827–4834. Epub 2007.
16.
Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T: Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 2007;92:2712–2719. Epub 2007.
17.
Hsieh FJ, Chang FM, Huang HC, Lu CC, Ko TM, Chen HY: Computer-assisted analysis for prediction of fetal weight by ultrasound-comparison of biparietal diameter (BPD), abdominal circumference (AC) and femur length (FL). Taiwan Yi Xue Hui Za Zhi 1987;86:957–964.
18.
Ogilvy-Stuart AL, Hands SJ, Adcock CJ, Holly JM, Matthews DR, Mohamed-Ali V, Yudkin JS, Wilkinson AR, Dunger DB: Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. J Clin Endocrinol Metab 1998;83:3550–3557.
19.
Zawiejska A, Wender-Ozegowska E, Brazert J, Sodowski K: Components of metabolic syndrome and their impact on fetal growth in women with gestational diabetes mellitus. J Physiol Pharmacol 2008;59(suppl 4):5–18.
20.
Inoue S, Takamoto N, Akahori Y, Masumoto A, Nakatsukasa H, Msuyama H, Hiramatsu Y: Elevated level of serum retinol-binding protein 4 in pregnancy induced hypertension. J Obstet Gynaecol Res 2009;35:293–300.
21.
Laudes M, Oberhauser F, Bilkovski R, Schubert M, Udelhoven M, Wassmer G, Roth B, Krone W: Human fetal adiponectin and retinol-binding protein (RBP)-4 levels in relation to birth weight and maternal obesity. Exp Clin Endocrinol Diabetes 2009;117:146–149.
22.
Quadro L, Blaner WS, Salchow DJ, Vogel S, Piantedosi R, Gouras P, Freeman S, Cosma MP, Colantuoni V, Gottesman ME: Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J 1999;18:4633–4644.
23.
Leturque A, Ferre P, Burnol AF, Kande J, Maulard P, Girard J: Glucose utilization rates and insulin sensitivity in vivo in tissues of virgin and pregnant rats. Diabetes 1986;35:172–177.
24.
Green MH, Green JB: The use of model-based compartmental analysis to study vitamin A metabolism in a non-steady state. Adv Exp Med Biol 2003;537:159–172.
25.
Cifelli CJ, Green JB, Green MH: Dietary retinoic acid alters vitamin A kinetics in both the whole body and in specific organs of rats with low vitamin A status. J Nutr 2005;135:746–752.
26.
Hultman K, Alexanderson C, Mannerås L, Sandberg M, Holmäng A, Jansson T: Maternal taurine supplementation in the late pregnant rat stimulates postnatal growth and induces obesity and insulin resistance in adult offspring. J Physiol 2007;579:823–833. Epub 2007.
27.
Vaisbuch E, Romero R, Mazaki-Tovi S, Erez O, Kim SK, Chaiworapongsa T, Gotsch F, Gabor TN, Dong Z, Pacora P, Lamont R, Yeo L, Hassan SS, Kusanovic JP: Retinol binding protein 4 – a novel association with early-onset preeclampsia. J Perinat Med 2010;38:129–139.
28.
Mazaki-Tovi S, Romero R, Vaisbuch E, Kusanovic JP, Chaiworapongsa T, Kim SK, Mittal P, Dong Z, Pacora P, Yeo L, Hassan SS: Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus. J Perinat Med 2010;38:147–155.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.